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Since the early days of immunology, it has been considered that high viru- 
lence and recency of isolation from pathological material were essential attri- 
butes  of strains of bacteria to be used in production  of superior immunizing 
agents. In spite of a  surprising paucity of supporting factual information this 
concept has pesisted. 
Perhaps in no field of investigative immunology has the theory of an essential re- 
lationship  of virulence to  immunogenicity been  accepted more widely than  it  has 
been in relation to the development of immunizing agents against typhoid. As early 
as  1910, Leishman (1)  pointed out  that employment of highly virulent cultures  of 
Salmonella typhosa appeared to have certain theoretical advantages in the preparation 
of typhoid vaccines. Perry, Findlay, and Bensted (2), who employed active-immunity 
protection tests on mice, concluded  that the more highly virulent the strains of S. 
typhosa employed in preparing vaccines,  the greater was the immunizing activity of 
the resultant products. Similar  conclusions  were reached by Arkwright (3),  Grinnell 
(4), and Brown (5). In many of these earlier  investigations, however, virulence and 
avimlence was not dearly distinguished  from smooth-rough variation of strains; in 
fact, virulence  and smoothness (also avirulence and roughness)  generally were con- 
sidered  essentially synonymous. 
One of the  most comprehensive studies of the relationship of virulence to anti- 
genicity of S. typhosa cultures was conducted by Siler and his associates  at the Army 
Medical  School  (6).  This investigation included  a  study of seven strains of varied 
virulence and it was found that, as measured by active-immunity mouse-protection 
tests  and  by "0"  agglutinin  and  mouse-protective antibody  responses  in  human 
volunteers, vaccines prepared from virulent strains were more highly immunogenic 
than were those prepared from avirulent strains. 
Felix  (7) likewise reported that highly virulent strains of S. typhosa exhibited  the 
greatest immunizing activity. He placed major emphasis on  the  r61e played by Vi 
antigen both in virulence and in immunogenicity. 
There is, however, no unanimity of opinion in regard to any essential  relationship 
between virulence and immunogenicity. This is evidenced  more by the development 
of certain immunizing agents and methods than by any specific investigations of the 
phenomenon itself.  It is  not  difficult  to  understand  why there is  no  unanimity of 
opinion in  regard  to  the supposed mutual interdependent  relationship  of virulence 
and immunogenicity since there has been a marked lack of uniformity in the experi- 
mental techniques employed in the various investigations and most of the published 
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conclusions have been based on experiments inadequate both in scope and in design. 
In a recent review of the available evidence, Dubos (8) concluded that, in view of the 
meager information available, the popularly accepted concept was an unwarranted 
generalization. Furthermore, he concluded that immunogenicity of organisms was de- 
pendent upon the presence of specific cellular structures  or components capable of 
eliciting an immune response in the host and that the presence of such components 
was not necessarily interdependent with virulence. In many instances the presence 
and activity of such components has been well established, particularly in the pneu- 
mococci  (capsular polysaccharides), the streptococci (M  antigen),  and  even  in  the 
group of Gram-negative enteric organisms  (O  antigens, Vi antigen).  Thus,  Dubos' 
contention can be accepted without serious reservation. 
Recent  isolation of an  avirulent  culture  of S.  typhosa from Boxill (9),  the 
carrier of strain 58 (Panama Carrier), and the in vitro production by nutritional 
means,  of an  avirulent culture  of the parent  strain, have permitted a  direct 
comparison  of  the  immunogenicity  of  virulent  and  avirulent  strains  of  S. 
typhosa of common  origin. It was  the objective of the investigation reported 
here  to  compare,  by laboratory means,  the  immunogenicity of  these  closely 
related virulent and avirulent strains of S. typhosa. 
EXPERIMENTAL 
Strains Us*d.--Four strains of S. typhosa were employed in this study. They were related 
in so far as they were isolated, or were derived from isolates, from the same carrier, Boxill, 
the source of the strain employed as routine for production of typhoid vaccine by the Army 
Medical Department. The designation, history of isolation, and maintenance of these strains 
is as follows:- 
Strain 5&--The regular vaccine strain, isolated from Boxill in 1934 and maintained in the 
lyophilized state since 1936. 
Strain  58V.--A culture isolated from  Boxill in August,  1948. 
Strain  58B.--The original strain 58 maintained in a  chemically  defined amino acids-in- 
organic  salts-glucose rnedinm  I for 47 daily transfers. 
Strain 58A.--The original strain 58  maintained in the chemically defined medium without 
glucose for 46 dally transfers. 
Laboratory studies revealed that strains 58 and 58B were mixtures of V and W forms (10) 
although the former were predominant. Strain 58V contained only V forms and strain 58A 
contained  only W form organisms.  Aside from  the occurrence of W forms, strains 58, 58V, 
and 58B qualitatively were identical in their content of somatic antigens (IX, XII, and Vi), 
and in regard to their other morphological, cultural, and  biochemical characteristics.  Strain 
58A, containing only W form organisms, was devoid of Vi antigen. 
Virulence Te~ts.--The virulence for mice of each of the strains of S. typhosa was determined 
by means of the intraperitoneal injection of graded doses of 16 hour cultures of the organisms 
suspended  in 5 per cent hog  gastric mucin  (Wilson  1701-W).  Cultures for preparation of 
1  The amino acids-inorganic salts medium had the following composition: d/-alanine, dg- 
valine,  l-leucine, amino-acetic acid, /-proline,  /-hydroxyproline,  d/-aspartic acid, and /~glu- 
tamic  acid, x~/1500; dl-methionine,  d/-phenylalanine,  /-tyrosine, l-arginine,  /-hisfidine,  dg- 
lysine,  and  /-cystine,  ~/4000;  l-tryptophane,  ~r/20,000;  KH2PO4, =/30;  MgSO4.TH20, 
xr/6000; pH 7.6. Glucose, as sterile supplement,  ~r/80. H.  C.  BATSON~ M, LANDY~ AND  M.  BROWN  233 
challenge suspensions of strains 58 and 58V were grown on veal infusion media while cultures 
of  strains 58B and 58A were grown in  the chemically defined  amino acids-inorganic salts 
medium, with and without glucose,  respectively. 
The mice employed in these virulence tests were 14 to 16 gin. white Swiss mice (Bagg strain) 
equally divided as to sex. In all mouse tests included in these studies, selection and assignment 
of mice to jars in  groups of five, location of the groups (jars) in the test-animal room, and the 
TABLE  I 
Virulence for Mice of S. typhosa, Strains 58 and 58V 
Challenge dose  Strain 58  Strain 58V  (in 0.5 ml. of $ per cent mucin) 
5 
50 
500 
5,000 
30,000 
300,000 
3,000,000 
30,000,000 
13/20" 
lS/2O 
17/20 
19120 
1/20 
3/20 
8/20 
20/20 
* Numerators denote number of deaths in 72 hours; denominators, total  mice injected. 
TABLE  II 
Virulence for Mi~e of S. typhosa, Strains 58B and 58.4 
Challenge dose  Strain 58B  Strain 58A  (in 0.5 nil. of 5 per cent mucin) 
3 
30 
300 
3,000 
80,000 
800,000 
8,000,000 
1/20" 
9/20 
10/20 
17/20 
1/20 
6/20 
16/20 
* Numerators denote number of deaths in 72 hours; denominators, total mice injected. 
order of injection by groups all were determined by randomization procedures. The  temper- 
ature of the test-animal room was maintained at 80  ° ±  I°F. 
Results of the virulence tests, in terms of the number of mice dying in 72 hours out of the 
total injected, are presented in Tables I and II. 
As can be  seen from  the results presented in Tables I  and II, strains 58 and 58B were 
typically virulent strains (~0's  =  <5 and 180  organisms, respectively),  while strains 58V 
and 58A were relatively avirulent (ra)50's =  3,000,000 and 1,750#00 organisms, respectively). 
Preparation of Vacdnes.--The method employed for  the production of experimental vac- 
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in preparation of typhoid vaccine for the Armed Forces (11). Thus, the organisms were grown 
on solid media for 24 hours at 37°C.,  suspended in saline, killed by heating to 56°C.  for 1 hour, 
and preserved with 0.5 per cent phenol. Routine sterility, safety, and toxicity tests were run 
on each vaccine and identification tests were performed by immunization of rabbits with three 
injections of 0.5 ml. subcutaneously, 1.0 ml. and 1.0 ml. intravenously at 7 day intervals. One 
week following immunization all rabbits  were bled and the sere were  titrated  for typhoid 
H  and O aggintinins. On the basis of these agglutination tests, no differences in the agghitino- 
genie activity of the experimental vaccines were observed. 
TABLE  III 
Survival  of Mice Immunized  with  Vaccines Prepared from S.  typhosa, Strains  58 and 58V, 
and Challenged with Strain 63* 
Vaccine  made from 
Strain 58 (virulent) 
Strain 58V (avirnlent) 
Vaccine dose, ml. 
0.003  0.012  0.048  None  __  __  __  (cootro~____~) 
3/15~  9/15  i3/15  i/19 
8/14  t  12/15  [15/15  [ 
* Challenge dose, 5,000 organisms suspended in 0.5 mi. of 5 per cent mucin. 
Numerators denote number of survivors at 72 hours; denominators, total mice tested. 
TABLE  IV 
SutUral of Mice Immunized with  Vaccines Prepared .from S. typhosa, Strains  58B and 58,4, 
and Challenged with Strain 63* 
Vaccine made from 
Strain 58B (virulent) 
Strain 58A (avirulent) 
Vaccine dose, ml. 
0.oo6  .o12  0.o24  o.o48  (coN~nels) 
-- 
7/30  8/29  15/30  18/30  2/13 
* Challenge dose, 10,000 organisms suspended in 0.5 ml. of 5 per cent mucin. 
Numerators denote number of survivors at 72 hours; denominators, total mice tested. 
Mouse-Protection Potency Tests 
Mouse-protection potency tests on the experimental vaccines were run in pairs, i.e. vac- 
dues prepared from strains 58 and 58V were compared directly in one assay, while vaccines 
from  strains 58B  and  58A were  compared in another. The assay procedure employed was 
based on the use of graded doses of vaccine and a constant challenge dose of viable S. typhosa 
suspended in 5 per cent mucin since a previous study (12) indicated that use of this method 
permits comparisons of greater precision than are obtained by procedures more commonly 
employed (13,  14).  The mice employed in these assays were 15 to 17 gin., male, white Swiss 
mice (CFW strain). All immunizing injections were made intraperitoneally, employing appro- 
priate dilutions of vaccine made up to 0.5 ml. in each case, and 6 days later all mice were 
challenged by the same route with mucin suspensions of the test organism S. typhosa, strain H.  C.  BATSON~ 1~.  LANDY~ AND  M.  BROWN  235 
~  5.0 
0.00:5  0.012  0.048 
VACCINE  DOSE (mrs.) 
FXG.  1.  Mouse-protection  potency  tests  on  vaccines prepared from  naturally occurring 
virulent (58)  and avirulent (58V)  strains of S. typhosa. 
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FIG. 2.  Mouse-protection potency tests on vaccines prepared from S. typhosa strains 58A 
and 58B. 
63 (6). Deaths among the challenged mice within 72 hours were recorded and the absolute 
potency of each vaccine, in terms of ED~0's, and the relative potency of each pair of vaccines 
were estimated by the methods proposed by Bliss (15,  16). The results of these tests are pre- 
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The estimates of absolute and relative protective potency of the two vaccines 
prepared  from  virulent  strains  revealed  no  conclusive  evidence  of  superior 
immunogenicity of these products over that of those prepared from the aviru- 
lent  strains.  Repeated  tests have  yielded relative potencies of these  pairs of 
vaccines made from virulent and avirulent strains varying from 0.97  to 2.02. 
In each case the 95 per cent confidence limits of the experimentally determined 
EDs0 values overlapped to such an extent that there was no statistically sig- 
nificant evidence of any true differences in potency. 
TABLE V 
Typhoid 0 Agglutinin Tilers of Sera from Individuals Immunized wStk Vaccines Prepared/tom 
S. typhosa, Strains 58B and 58.4 
No. of  O agglutlnin  titers  I Meantiters 
Vaccine made from  persons  -- --  --  I  (geo- 
1:80  1:160  1:320  1:640  1:1,280 metrlc___~) 
Strain 58B (virulent)  11  1  2  4  3  1  341 
Strain 58A (avirulent)  113121315[2111273 
TABLE VI 
Typhoid H  Agglutinin  Titers of Sera from Individuals  Immunized  with  Vaccines Prepared 
from S. typhosa, Strains 58B and 58.4 
No. of  H agghtlnin  titers  ]  I  Mean  titen 
Vaccine made from  persons  1:80  1:1~  --~."  540  (gco-  metri¢______~) 
Strain 58B (virulent)  11  2  0  5  2  362 
Strain 58A (avirulent)  I  13  I  0  I  4  I  4  [  4  [  355 
Immunological Response of Human Beings 
A  series of 26 individuals  2 was  immunized  with vaccines prepared from  virulent (58B) 
and avirulent (583,) strains of S. typhosa; 13 individuals with each product. None of the indi- 
viduals included  in the study had a history of typhoid or typhoid-like infections and none 
previously had been immunized with typhoid vaccine. 
Individuals were selected at random for immunization  with each vaccine and three injec- 
tions of 0.5 ml. each were given at weekly intervals. A complete record of systemic and local 
reactions following each injection was obtained. The observed reactions, as a whole, were mild 
and were essentially identical both in occurrence and severity in the two groups. 
The authors wish to express their appreciation to Dr. Harry E. Morton, Department of 
Bacteriology,  School of Medicine,  University of Pennsylvania, for his cooperation  in  this 
investigation, and to students of the Department who served  as volunteer subjects in the 
study of the antibody response to immunization  with the experimental vaccines. H.  C.  BATSON, M.  LANDY, AND M.  BROWN  237 
Blood specimens were obtained from each individual immediately prior, and 21 days sub- 
sequent to, immunization. All serum specimens were titrated for typhoid H and O aggiutinins 
and for mouse-protective antibodies. No evidence was obtained of the existence of specific 
immune antibodies in any of the serum specimens collected prior to immunization. 
Sera from two individuals immunized with vaccine prepared from strain 58B 
failed  to  yield agglutination and  mouse-protection antibody determinations 
both of which were satisfactory. The distribution of O and H  agglutinin titers 
and geometric mean titers of the remaining 24 individuals  in the two immuniza- 
tion groups is presented in Tables V and VI. While the mean titers were slightly 
higher in the group given vaccine prepared from strain 58B, the difference was 
not significant  3. 
The method of determining the mouse-protective potency of the sera was based on obser- 
vations previously reported (17) that assays based on graded doses of serum and a constant 
challenge dose of viable organisms yield more reliable results than do tests in which graded 
challenge doses and a constant serum dose are employed. A two dose serum protection test 
was used, the doses differing by a fourfold increment and so selected as to bracket the expected 
EDs0 value determined by preliminary screening tests. Male, white Swiss mice (CFW strain), 
weighing 15 to 17 gin., were used in all serum assays. Serum dilutions were injected intra- 
peritoneally and all mice were challenged 1 hour later by the same route with 1,000 S. ty- 
phosa, strain 63, suspended in 5 per cent mucin. Twenty mice (four groups of five each) were 
tested at each serum dose. Tests were considered satisfactory only when 1 to 9 mice given the 
smaller serum dose, and 11 to 19 given the higher serum dose, survived for 72 hours. Tests 
were repeated until two satisfactory assays were obtained on each serum specimen. In each 
test the relative potency of each serum (16), in terms of mouse-protection units, was calcu- 
lated in reference to a standard antiserum arbitrarily designated as possessing 100 mouse- 
protective  units per  ml. The individual mouse-protective potencies,  nmana, and standard 
deviations of such potencies of the sera from each study group are presented in Table VII. 
The observed close agreement between the mean mouse-protective potencies 
obviously was a  chance circumstance when the standard deviations of the two 
series are  note.  The  entire  data,  in  terms  of  mouse-protective  units, were 
analyzed statistically by analysis of variance (18). Results of the analysis are 
presented in Table VIII. 
The analysis presented in Table VIII reveals the futility of attempting to 
draw conclusions from mouse-protective potency data such as were obtained in 
this study.  It  can be seen that  although differences between the  sera of in- 
dividuals were  significantly greater than were  those  between repeat  tests on 
the same sera, the former contributed overwhelmingly more to the total vari- 
ation than did differences in responses to the two types of vaccine. In fact, it 
s Additional typhoid O and H aggiutinin titrations were run on serum specimens obtained 
from the same study individuals at approximately 90 and 180 days following immunization. 
At each postimmunization period the  geometric mean  agglutinin  titers  were significantly 
lower than at the preceding period, but at no time did the titers of the two immunization 
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TABLE  VII 
Mouse-Protective Potency of Sera from Individuals  Immunized with  Vaccines Prel~ared  from 
S. typhosa, Strains 58B and 58.4 
Vaccines  made from strain 58B  Vaccines made from strain 58A 
(virulent)  (avirulent) 
Protective potency* 
Serum No. 
6 
8 
10 
12 
14 
16 
18 
20 
Ist test  2d test  Mean 
226  245  236 
76  100  88 
42  139  91 
316  153  235 
172  259  216 
90  142  116 
1,148  800  974 
258  597  428 
240  225 
153  217 
316  216 
Serum  Protective potency* 
No.  1st tes---t  2d tes~  M--ean 
1  401  455  428 
3  207  237  222 
5  189  153  171 
7  125  178  152 
9  595  873  734 
11  !  358  634  496 
136  437  287 
212  500  356 
13 
15 
17  167  185  176 
19  321  497  409 
21  250  373  312 
23  189  282  236 
25  232  351  292 
22 
24 
26 
m  m 
233 
185 
266 
Group mean potency .........  279  328 
Standard deviation:[:  ..........  250  161 
* Determined in relation to a reference serum arbitrarily designated as having a  mouse- 
protective potency of 100. 
:~ Calculated from mean potencies of individuals. 
TABLE  VIII 
Analysis  of Variance of Mouse-Protective Potency  Data  Presented in  Table VII 
Degrees  Mean  ISource of variation  of freedom  square 
Between vaccine groups .................................  1  29,447 
Between individuals within groups ........................  22  ] 86,353 
Between repeat tests on individual sera ....................  I  24  I 14,618 
Variance 
ratio 
0.34:~ 
5.91"** 
Not significant at the 5 per cent level. 
*** Exceeds the 0.1 per cent level of significance. 
can be stated  that  it is extremely improbable  that  there should be such close 
agreement between immunization  groups when the sera of different individuals 
and  the repeat  tests themselves were  subject  to such great variation.  If there 
is  a  true  difference  in  response  to  vaccines  of  these  two  types,  it  is  obvious 
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fore the significance of such differences can be established.  Certainly, no evi- 
dence was obtained in this study indicating that there were any true differences 
in the responses to the two products employed. 
DISCUSSION 
The experimental  results  reported in this investigation fail to indicate the 
existence of any essential  relationship  between  the virulence,  as measured in 
mice, and the immunogenicity of the strains of S. typhosa employed. Further- 
more, no quantitative differences in the immunogenicity of strains of different 
virulence  were established.  The latter may have resulted  from the absence of 
any appreciable  true differences or the inadequacy of the methods employed to 
establish  the existence of such differences beyond the  limits of experimental 
uncertainty. 
It is becoming more generally recognized that virulence,  rather than being 
a specific, intrinsic  attribute of an organism, is a manifestation of a combina- 
tion of factors pertaining to the infectious agent, the  affected host, and other 
factors both  known and  unknown.  In  other  studies recently  completed  in 
these laboratories  (19), it was found that the degree  of difference in virulence 
for mice of strains 58 and 58V (also 58B and 58A) depended  upon the method 
of testing for virulence.  Thus, the distinction between  the virulence  of these 
strains was marked when tested by the intraperitoneal-mucin technique but 
was  of questionable  certainty when  tested by the intracerebral iniection of 
saline suspensions of the organisms. 
Under  both  experimental  and  natural  conditions,  there  undoubtedly are 
many factors complementing  the infective  process which either are unrecog- 
nized or for which no quantitative methods of estimation are available.  If in 
any one particular situation one factor (or a combination  of factors)  uniquely 
essential  to  those  conditions  is  absent  or  is  inadequate to  complement  the 
process, failure to obtain evidence of virulence would result. Thus, experimental 
demonstration of  avirulence  may be  the  result  of fortuitous circumstances 
rather than of  any true  inadequacy of the potential  capability of the test 
organisms to parasitize  the host. 
The possibility  of apparent  marked differences  in virulence  of strains  of 
organisms  resulting  from  chance  circumstances  can largely be eliminated by 
proper planning and execution of experiments.  For example, the concomitant 
testing of virulent and avirulent strains such as 58 and 58V (or 58B and 58A) 
in a single experiment  with the environmental conditions and such reagents as 
mucin being  common  to both,  and unknown differences in resistance  of in- 
dividual mice or progressive changes in challenge suspensions being distributed 
throughout the experiment by proper  randomization, tend  to minimize  the 
possible introduction of bias resulting from chance association  of unknown in- 
adequate biological factors with an experimental factor of prime interest. 240  VINULENCE  AND  IM~UNOGENICITY  OF  S.  TYPHOSA  STRAINS 
In this study, strains 58 and 58V were equal in regard  to their  content of 
known somatic antigens IX, XII, and Vi.  The prime difference between these 
strains was the inability of the latter, when suspended in 5 per cent mucin, to 
exhibit comparable virulence for mice by intraperitoneal injection.  This ob- 
servation clearly indicates that Vi antigen, regardless  of its r61e in immuno- 
genicity, is not an independent virulence entity. 
Strains  58B  and  58A  differed in that  the  former was predominantly a  V 
form strain (a few W  form organisms were present) while 58A was a pure W 
form strain. Thus, these two strains were characterized by the presence and 
absence, respectively, of Vi antigen. The difference in virulence of these two 
strains ordinarily would have been assumed to be conditioned by this difference 
in Vi antigen content except for the aforementioned observation of virulence 
and avirulence of strains 58 and 58V, both of which contained Vi antigen. 
Failure to demonstrate virulence of strains 58V and 58A indicates that some 
factor or component essential to or complementing the experimental infective 
process was missing; a factor possessed by strains 58 and 58B. All that can be 
surmised regarding its nature is that it is independent of the somatic antigens 
IX, XII, and Vi; it is not a definitive characteristic of V form strains; and it 
is not of demonstrated immunogenic importance. If the component responsible 
for the differentiation between virulent and avirulent strains were immuno- 
genically active, it is possible that it was destroyed or rendered inactive by 
the heat or phenol employed in preparing the experimental vaccines. Felix and 
Bhatnagar  (20)  have reported such  effects of various killing and preserving 
agents on Vi antigen and, while the explanation of the findings reported here 
cannot very well be based  on Vi antigen, other immunologicaUy active com- 
ponents could exhibit comparable lability. It has been established that mer- 
thiolate is a mild killing agent and does not destroy Vi antigen (21).  Vaccines 
prepared in these laboratories from strains 58, 58V, 58B,  and  58A using mer- 
thiolate as a  killing and preserving  agent  have  shown immunizing activity 
entirely  comparable  to  those produced  by  the  heat-phenol  method.  These 
results cast doubt on, but do not negate, the foregoing supposition. 
The comparable protective potency of vaccines produced from strains 58B 
and 58A, as measured by active-immunity mouse-protection tests, may appear 
to cast doubt on the r61e of Vi antigen in determining the immunogenicity of 
typhoid vaccine.  Failure  to  obtain  conclusive evidence of difference in  the 
potency of these two products could have resulted from (a)  non-existence of 
any difference, (b) a quantitative difference of such minor magnitude that the 
experimental design selected was of insufficient scope and sensitivity for its de- 
tection with certainty, or  (c)  inappropriateness of the selected experimental 
conditions for detecting  the  existence  of  a  difference, either  qualitative  or 
quantitative. 
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vaccines made from strains 58B and 58A,  the findings do not necessarily pre- 
clude the existence of a true difference. Strain 58B was predominantly a V form 
strain  and  did  contain Vi  antigen while  strain  58A  did not.  Other  active- 
immunity mouse-protection tests conducted in these laboratories, employing 
somewhat dissimilar experimental conditions, repeatedly have indicated that 
vaccines prepared from V form strains are more highly immunogenic than are 
those prepared from W  form strains. The experimentally determined ratio of 
the protective potencies of these two products,  1.79  (Fig. 2), was well within 
the 95 per cent confidence limits of the ratio and, therefore, no statistical justi- 
fication existed for stating that a difference in potency existed. Likewise, there 
was no justification for stating that a  difference did not exist. The observed 
difference could well have been a  chance occurrence but the  best estimate of 
relative potency was  1.79. Establishment of statistical significance of a  true 
difference of this magnitude would have required a more elaborate or extensive 
experiment. 
It is conceivable that the experimental conditions selected, such as strain of 
mice, strain of challenge organisms, etc., inadvertently were such as to pre- 
clude or at least to minimize the demonstration of differences in potency of'  the 
experimental vaccines. In another series of investigations currently being pur- 
sued  in  these  laboratories it  has  been  found, for example,  that S.  typhosa, 
strain 63, is markedly less virulent than is strain 58 but that demonstration of 
this difference can be  accomplished only by the deliberate use of relatively 
resistant mice or other experimental factors unfavorable to high mouse mortal- 
ity.  In  all active-immunity mouse-protection  tests  presented  in  this  study, 
strain  63  was used  as  the  challenge organism.  Differences in  the protective 
potency of the vaccines being studied might well have been more clearly evi- 
dent if other testing conditions, such as a more highly virulent challenge strain, 
had been employed. Studies in this regard are now in progress and will be made 
the basis of a  separate report. 
Regardless of minor differences in potency of vaccines prepared from strains 
58B  and 58A,  which could be dependent upon the presence or absence of Vi 
antigen, it appears that whatever the nature of the factor essential to the viru- 
lence of strains of S. typhosa it is not of demonstrable immunogenic importance. 
This is evidenced particularly by the relative potency (Fig.  1) of vaccines pre- 
pared from the naturally occurring virulent and avirulent strains 58 and 58V. 
Such  a  conclusion is  strictly valid only on the  assumption that  survival of 
vaccinated mice, when subjected to challenge, is dependent upon the existence 
of a true state of immunity resulting from injection of the vaccines. While the 
true immunological significance of the mouse-protection test has not been es- 
tablished incontrovertibly, results of cross-protection tests (22) have confirmed 
the specificity of the method. 
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beings  (Tables  V and VI)  immunized  with vaccines  prepared  from virulent 
and avirulent strains likewise failed to furnish any evidence of a difference in 
the immunogenic potency of the two products.  Although agglutinin response 
is considered to be less biologically significant than is mouse-protective  potency 
(23), the close comparability of the responses to the two vaccines affords im- 
portant supportive evidence. 
Results of the mouse-protection  tests on the human sera likewise afforded 
no evidence of a qualitative or quantitative difference in the response to vac- 
cines made from relatively virulent and avirulent stains.  Of equal or greater 
interest, however, was the observation  of the extreme variations in the results 
of such tests performed on sera from different individuals  given the same vac- 
cine and even in the results of repeat tests on the same sera. These findings em- 
phasize the lack of reliability of quantitative data based on mouse-protection 
tests and reveal the need for further developmental  study of the technique and 
its utilization in immunological  investigations. 
It is appreciated that the results presented here do not necessarily refute the 
concept  that recently isolated, fully virulent, smooth strains of S. typhosa are 
to be preferred  for the production of typhoid vaccines. Rather, these  results 
may merely emphasize the inadequacies of the laboratory techniques available 
for evaluation  of such a concept. The strains considered to be virulent and aviru- 
lent may well be of equal virulence, either high or low, for man. The true state 
of protective immunity engendered in man by injection of vaccines made from 
these strains actually may be of entirely different orders of efficacy. If, however, 
these  true states are so contradictory to the reported experimental  findings, 
further research of this nature not only may be fruitless,--it may be mislead- 
ing. 
SUMMARY 
An investigation of the immunogenicity of vaccines prepared  from closely 
related virulent and avirulent strains of S. typhosa is reported. 
No evidence was obtained of any essential relationship between the virulence 
of the strains employed and their immunogenicity, as  determined by active- 
immunity mouse-protection  tests and by the agglutinin and mouse-protective 
antibody response in human beings. 
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